Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Pharma
Oncology
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Trending
Supply Chain
AI and Machine Learning
Awards
Outsourcing Awards
Innovation Awards
AI Innovation Awards
Pharma Marketing Awards
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Subscribe
Pharma
Oncology
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Trending
Supply Chain
AI and Machine Learning
Awards
Outsourcing Awards
Innovation Awards
AI Innovation Awards
Pharma Marketing Awards
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
infectious disease
Pharma
Asahi Kasei makes good on AiCurus buyout with new FDA nod
Roughly half a year after the close of its deal to acquire Bayer spinout AiCurus, Asahi Kasei’s $920 million bet has paid off with an FDA nod.
Fraiser Kansteiner
Oct 12, 2026 10:28am
Regeneron to invest $2B in new Saratoga Springs production plant
Nov 18, 2025 10:15am
CorMedix buys Melinta for $300M, adding 7 marketed products
Aug 7, 2025 11:36am
GSK snags FDA approval for new UTI treatment Blujepa
Mar 25, 2025 2:20pm
Mpox still a risk as new awareness campaigns launch
Aug 10, 2023 10:15am
Pfizer, Gilead, GSK to dominate infectious disease market
Jul 20, 2023 9:45am
